Literature DB >> 19041762

Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis.

Clémence Blouet1, Hiraku Ono, Gary J Schwartz.   

Abstract

p70 S6 kinase 1 (S6K) is a major downstream effector of the mammalian target of rapamycin (mTOR), primarily implicated in the control of protein synthesis, cell growth, and proliferation. Here we demonstrate that specific bidirectional molecular targeting of mediobasal hypothalamic (MBH) S6K activity in rats is sufficient to significantly alter food intake, body weight, hypothalamic orexigenic neuropeptide expression, hypothalamic leptin sensitivity, and the metabolic and feeding responses to a fast. In addition, adenoviral-mediated constitutive activation of MBH S6K improved cold tolerance and protected against high-fat diet-induced overeating, fat deposition, and insulin resistance. Our results provide direct evidence that MBH S6K activity bidirectionally drives behavioral and metabolic determinants of energy balance and promote the assessment of MBH S6K activity as a therapeutic target in metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041762      PMCID: PMC2637401          DOI: 10.1016/j.cmet.2008.10.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  31 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

3.  Central administration of oleic acid inhibits glucose production and food intake.

Authors:  Silvana Obici; Zhaohui Feng; Kimyata Morgan; Daniel Stein; George Karkanias; Luciano Rossetti
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

4.  Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition.

Authors:  Anthony V Azzara; Jeremy P Sokolnicki; Gary J Schwartz
Journal:  Physiol Behav       Date:  2002-11

5.  Mammalian TOR: a homeostatic ATP sensor.

Authors:  P B Dennis; A Jaeschke; M Saitoh; B Fowler; S C Kozma; G Thomas
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

6.  NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting.

Authors:  Gabriella Segal-Lieberman; Daniel J Trombly; Viral Juthani; Xiaomei Wang; Eleftheria Maratos-Flier
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-02-11       Impact factor: 4.310

7.  Localization of translational components at the ultramicroscopic level at postsynaptic sites of the rat brain.

Authors:  Chie Asaki; Nobuteru Usuda; Ayami Nakazawa; Kiyokazu Kametani; Tatsuo Suzuki
Journal:  Brain Res       Date:  2003-05-16       Impact factor: 3.252

8.  Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement.

Authors:  Hiraku Ono; Hitoshi Shimano; Hideki Katagiri; Naoya Yahagi; Hideyuki Sakoda; Yukiko Onishi; Motonobu Anai; Takehide Ogihara; Midori Fujishiro; Amelia Y I Viana; Yasushi Fukushima; Miho Abe; Nobuhiro Shojima; Masatoshi Kikuchi; Nobuhiro Yamada; Yoshitomo Oka; Tomoichiro Asano
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

9.  Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia.

Authors:  Kevin D Niswender; Christopher D Morrison; Deborah J Clegg; Ryan Olson; Denis G Baskin; Martin G Myers; Randy J Seeley; Michael W Schwartz
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

10.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.

Authors:  Diane C Fingar; Sofie Salama; Christina Tsou; Ed Harlow; John Blenis
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

View more
  90 in total

Review 1.  Homeostatic regulation of protein intake: in search of a mechanism.

Authors:  Christopher D Morrison; Scott D Reed; Tara M Henagan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-08       Impact factor: 3.619

Review 2.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

3.  p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake.

Authors:  Yossi Dagon; Elizabeth Hur; Bin Zheng; Kerry Wellenstein; Lewis C Cantley; Barbara B Kahn
Journal:  Cell Metab       Date:  2012-06-21       Impact factor: 27.287

Review 4.  Leptin signalling pathways in hypothalamic neurons.

Authors:  Obin Kwon; Ki Woo Kim; Min-Seon Kim
Journal:  Cell Mol Life Sci       Date:  2016-01-19       Impact factor: 9.261

5.  SIRT1 and CLOCK 3111T> C combined genotype is associated with evening preference and weight loss resistance in a behavioral therapy treatment for obesity.

Authors:  M Garaulet; A Esteban Tardido; Y-C Lee; C E Smith; L D Parnell; J M Ordovás
Journal:  Int J Obes (Lond)       Date:  2012-02-07       Impact factor: 5.095

Review 6.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 7.  Leptin signaling and leptin resistance.

Authors:  Yingjiang Zhou; Liangyou Rui
Journal:  Front Med       Date:  2013-04-12       Impact factor: 4.592

Review 8.  Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance.

Authors:  François Chabot; Alexandre Caron; Mathieu Laplante; David H St-Pierre
Journal:  World J Diabetes       Date:  2014-06-15

Review 9.  Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models.

Authors:  Alberto A Barrios-Correa; José A Estrada; Irazú Contreras
Journal:  J Mol Neurosci       Date:  2018-10-03       Impact factor: 3.444

Review 10.  PTEN in cancer, metabolism, and aging.

Authors:  Ana Ortega-Molina; Manuel Serrano
Journal:  Trends Endocrinol Metab       Date:  2012-12-12       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.